CNS Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CNSP | PCSA | BIVI | NIKI | NRSN | CRIS | |
|---|---|---|---|---|---|---|
| Market cap | 7.58M | 5.31M | 11.46M | 9.42M | 6.60M | 1.56M |
| P/E (TTM) | — | — | — | — | — | 0.5 |
| Forward P/E | -13.3 | -0.5 | -2.3 | — | -0.5 | -0.1 |
| Price/book | 0.4 | -16.7 | 1.0 | 0.1 | -3.6 | 0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −45.60% | −86.21% | −34.00% | −74.68% | −85.00% | −97.92% |
| Today | −2.81% | +25.00% | −5.04% | −24.50% | −4.92% | −4.16% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CNSP news ›Tag, You’re It: Modernizing Naval Maintenance Starts with the Tagout Process
By Lieutenant Alana Davis, U.S. Navy Introduction: When Maintenance Goes Wrong, or Doesn’t Go at All The Shipboard Tagout Process Today What does performing a tagout entail? You can start by reading the 100+ page NAVSEA published Tag-Out…
The Technical Signals Behind (JACS) That Institutions Follow
Stock Traders Daily Key findings for JACS Company (NASDAQ: JACS) - Full Alignment in Neutral Sentiment Favors Wait-and-See Approach - Breakdown is underway. If sustained, lower levels are expected. - Elevated downside risk as no additional…
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
A PPO, or preferred provider organization, is a type of health insurance plan that gives members a network of doctors and hospitals who agree to lower fees, while still allowing patients to see providers outside the network at higher cost.…
Key facts: CRS confident on FY2027; elects 3 directors
TradingView Key facts: CRS confident on FY2027; elects 3 directors - Carpenter Technology Corporation (CRS) stated that, looking into fiscal 2027, the company expressed confidence and momentum and signaled continued focus on future…
Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update
Nov 07, 2024, 16:05 ET – New Real World Study of 150,000 Patients Favors Caldolor over ketorolac – – DMD Program Receives FDA Orphan Drug & Rare Pediatric Disease Designations – "With a number of developments and growth opportunities…
NeoGenomics Expects $209 Million Third-Quarter Revenue as CEO Transition Set
NeoGenomics (NASDAQ: NEO) announced a leadership succession plan under which President and COO Warren Stone will become chief executive officer and join the board effective January 4, 2027. Current CEO Tony Zook will become executive…
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call September 30, 2026 12:00 PM EDTCompany ParticipantsRami Levin - President, CEO & DirectorSteve...
CNSY: CNSide surpassed coverage goals, began billing, and projects strong growth with new tests and sales team
TradingView CNSY: CNSide surpassed coverage goals, began billing, and projects strong growth with new tests and sales team CNSide achieved 158 million covered lives and began billing, with Q3 gross billings at $1.55 million on 222 tests.…
CytoMed Therapeutics narrows H1 2026 loss to S$1.79M
Management believes current resources and offering proceeds will cover needs for approximately a year, but says available capital could be exhausted sooner. CytoMed Therapeutics (GDTC) reported S$157,289 in revenue for the six months ended…
CNSY: Q3 gross billings hit $1.55M; expanded coverage and new tests drive strong Q4 outlook
TradingView CNSY: Q3 gross billings hit $1.55M; expanded coverage and new tests drive strong Q4 outlook Q3 2026 gross billings reached $1.55 million with 222 tests billed, and coverage expanded to 158 million lives. New test launches and…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com7
-
quiverquant.com3
-
manilatimes.net2
-
seekingalpha.com2
-
stocktitan.net2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.